Goldman SachsGSSELLApr 12, 2013Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
Normally does very well from January through until the end of April. Seem to have worked reasonably well this time but we are reaching the end of seasonal strength. Chart shows it has been struggling and has established a short-term downward trend in the last 2 weeks and is below its 20 day moving average and has started to underperform the S&P 500.